Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Kenneth Dunner"'
Autor:
Sharada Mokkapati, Vikram M. Narayan, Ganiraju C. Manyam, Amy H. Lim, Jonathan J. Duplisea, Andrea Kokorovic, Tanner S. Miest, Anirban P. Mitra, Devin Plote, Selvalakshmi Selvaraj Anand, Michael J. Metcalfe, Kenneth Dunner, Jr., Burles A. Johnson, Bogdan A. Czerniak, Tiina Nieminen, Tommi Heikura, Seppo Yla-Herttuala, Nigel R. Parker, Kimberley S. Schluns, David J. McConkey, Colin P. Dinney
Publikováno v:
Molecular Therapy: Oncolytics, Vol 26, Iss , Pp 141-157 (2022)
Interferon alpha (IFNα) gene therapy is emerging as a new treatment option for patients with non-muscle invasive bladder cancer (NMIBC). Adenoviral vectors expressing IFNα have shown clinical efficacy treating bacillus Calmette-Guerin (BCG)-unrespo
Externí odkaz:
https://doaj.org/article/5de742af926648bcab7840c44c6fac3e
Autor:
Qi Zhang, Bridget Riley-Gillis, Lina Han, Yanan Jia, Alessia Lodi, Haijiao Zhang, Saravanan Ganesan, Rongqing Pan, Sergej N. Konoplev, Shannon R. Sweeney, Jeremy A. Ryan, Yulia Jitkova, Kenneth Dunner, Shaun E. Grosskurth, Priyanka Vijay, Sujana Ghosh, Charles Lu, Wencai Ma, Stephen Kurtz, Vivian R. Ruvolo, Helen Ma, Connie C. Weng, Cassandra L. Ramage, Natalia Baran, Ce Shi, Tianyu Cai, Richard Eric Davis, Venkata L. Battula, Yingchang Mi, Jing Wang, Courtney D. DiNardo, Michael Andreeff, Jeffery W. Tyner, Aaron Schimmer, Anthony Letai, Rose Ann Padua, Carlos E. Bueso-Ramos, Stefano Tiziani, Joel Leverson, Relja Popovic, Marina Konopleva
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-13 (2022)
Abstract Despite high initial response rates, acute myeloid leukemia (AML) treated with the BCL-2–selective inhibitor venetoclax (VEN) alone or in combinations commonly acquires resistance. We performed gene/protein expression, metabolomic and meth
Externí odkaz:
https://doaj.org/article/d7945566353e4cff944fa98c53fc192d
Autor:
Qi Zhang, Bridget Riley-Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang, Saravanan Ganesan, Rongqing Pan, Sergej N. Konoplev, Shannon R. Sweeney, Jeremy A. Ryan, Yulia Jitkova, Kenneth Dunner, Shaun E. Grosskurth, Priyanka Vijay, Sujana Ghosh, Charles Lu, Wencai Ma, Stephen Kurtz, Vivian R. Ruvolo, Helen Ma, Connie C. Weng, Cassandra L. Ramage, Natalia Baran, Ce Shi, Tianyu Cai, Richard Eric Davis, Venkata L. Battula, Yingchang Mi, Jing Wang, Courtney D. DiNardo, Michael Andreeff, Jeffery W. Tyner, Aaron Schimmer, Anthony Letai, Rose Ann Padua, Carlos E. Bueso-Ramos, Stefano Tiziani, Joel Leverson, Relja Popovic, Marina Konopleva
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/0bea0028687644349367928f6f176be8
Autor:
Konrad Gabrusiewicz, Xu Li, Jun Wei, Yuuri Hashimoto, Anantha L. Marisetty, Martina Ott, Fei Wang, David Hawke, John Yu, Luke M. Healy, Anwar Hossain, Johnny C. Akers, Sourindra N. Maiti, Shinji Yamashita, Yuzaburo Shimizu, Kenneth Dunner, M. Anna Zal, Jared K. Burks, Joy Gumin, Felix Nwajei, Aras Rezavanian, Shouhao Zhou, Ganesh Rao, Raymond Sawaya, Gregory N. Fuller, Jason T. Huse, Jack P. Antel, Shulin Li, Laurence Cooper, Erik P. Sulman, Clark Chen, Changiz Geula, Raghu Kalluri, Tomasz Zal, Amy B. Heimberger
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Exosomes can mediate a dynamic method of communication between malignancies, including those sequestered in the central nervous system and the immune system. We sought to determine whether exosomes from glioblastoma (GBM)-derived stem cells (GSCs) ca
Externí odkaz:
https://doaj.org/article/a885c8148d76466880be7e6fe72a4220
Autor:
Jiexi Li, Zhengdao Lao, Wenting Liao, James W. Horner, Xueping Xu, Jielin Liu, Yohei Yoshihama, Shan Jiang, Hong Seok Shim, Max Slotnik, Chang-Jiun Wu, Kenneth Dunner Jr., Rumi Lee, Isha Khanduri, Christopher Terranova, Kadir Caner Akdemir, Deepavali Chakravarti, Kyle LaBella, Wen-Hao Hsu, Denise J. Spring, Y. Alan Wang, Ronald A. Depinho
Publikováno v:
Leading Edge of Cancer Research Symposium: Poster Session.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af5ca213e73d983e3493e5d4c181ced8
https://doi.org/10.52519/00065
https://doi.org/10.52519/00065
Autor:
Vanaja Konduri, Kenneth Dunner, William K. Decker, Shonda Wesson, Matthew M. Halpert, Emek Blair, Colby J. Hofferek, Pedram Salimpour, Chris D. Verrico, Jonathan Vazquez-Perez
Publikováno v:
Pain
Over the last 2 decades, affirmative diagnoses of osteoarthritis (OA) in the United States have tripled due to increasing rates of obesity and an aging population. Hemp-derived cannabidiol (CBD) is the major nontetrahydrocannabinol component of canna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ad0680de7f499f43d99110c898df1b
https://europepmc.org/articles/PMC7584779/
https://europepmc.org/articles/PMC7584779/
Autor:
Matthew Halpert, Chris Verrico, Shonda Wesson, Vanaja Konduri, Colby Hofferek, Jonathan Vazquez-Perez, Emek Blair, Kenneth Dunner, Pedram Salimpour, William K Decker
Publikováno v:
The Journal of Immunology. 204:67.11-67.11
Hemp-derived cannabidiol (CBD) is the major non-psychoactive component of cannabis and has been promoted as a potential treatment for a wide variety of disparate inflammatory conditions. Here we evaluated CBD for its ability to modulate the productio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f703fcecc0718193c429ca6516b5006
https://doi.org/10.4049/jimmunol.204.supp.67.11
https://doi.org/10.4049/jimmunol.204.supp.67.11
Autor:
Colin P.N. Dinney, Michael J. Metcalfe, Kenneth Dunner, Vikram M. Narayan, Nigel Parker, Andrea Kokorovic, Seppo Ylä-Herttuala, Sharada Mokkapati, Jonathan J. Duplisea, Bogdan Czerniak, Tommi Heikura, David J. McConkey, Amy Lim, Tiina Nieminen, Devin Plote
Publikováno v:
Journal of Clinical Oncology. 38:33-33
33 Background: Gene therapy for bladder cancer (BLCA) is rapidly evolving. We reported that intravesical adenoviral interferon-alpha (Ad-IFNα) produced a complete response in 35% of patients with BCG-unresponsive BLCA enrolled in a Phase II trial. L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::629cd63fc8e922aed361fcc0cd905581
https://doi.org/10.1200/jco.2020.38.5_suppl.33
https://doi.org/10.1200/jco.2020.38.5_suppl.33
Autor:
Shouhao Zhou, Anwar Hossain, Johnny C. Akers, Yuzaburo Shimizu, Erik P. Sulman, Laurence J.N. Cooper, Shulin Li, Jason T. Huse, Ganesh Rao, M. Anna Zal, Joy Gumin, Changiz Geula, Jack P. Antel, Anantha Marisetty, Raghu Kalluri, Aras Rezavanian, Luke M. Healy, Gregory N. Fuller, Jun Wei, Fei Wang, Sourindra Maiti, Tomasz Zal, Felix Nwajei, Amy B. Heimberger, Kenneth Dunner, Shinji Yamashita, Martina Ott, Yuuri Hashimoto, Jared K. Burks, Raymond Sawaya, Clark C. Chen, David H. Hawke, John Yu, Konrad Gabrusiewicz, Xu Li
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Oncoimmunology
Oncoimmunology
Exosomes can mediate a dynamic method of communication between malignancies, including those sequestered in the central nervous system and the immune system. We sought to determine whether exosomes from glioblastoma (GBM)-derived stem cells (GSCs) ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17650942906cb0475c4d180c59514fd2
https://doaj.org/article/a885c8148d76466880be7e6fe72a4220
https://doaj.org/article/a885c8148d76466880be7e6fe72a4220
Autor:
Nigel Parker, Amy Lim, Michael J. Metcalfe, Bogdan Czerniak, Vikram M. Narayan, Jonathan J. Duplisea, Sharada Mokkapati, Tommi Heikura, Tiina Nieminen, Seppo Ylä-Herttuala, Kimberly S. Schluns, Colin P.N. Dinney, Kenneth Dunner, Devin Plote, David J. McConkey
Publikováno v:
Journal of Clinical Oncology. 37:456-456
456 Background: Gene therapy for bladder cancer (BLCA) is rapidly evolving. We reported that intravesical adenoviral interferon-alpha (Ad-IFNα) produced a complete response in 35% of patients with BCG-unresponsive BLCA enrolled in a Phase II trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a30050290fdb94d383283dd40b4fabd6
https://doi.org/10.1200/jco.2019.37.7_suppl.456
https://doi.org/10.1200/jco.2019.37.7_suppl.456